Robotic Surgery Devices Global Market Report 2024

The robotic surgery devices market size has grown rapidly in recent years. It will grow from $6.84 billion in 2023 to $7.81 billion in 2024 at a compound annual growth rate (CAGR) of 14.0%. The increase observed in the historical period can be credited to the expanded utilization of surgical robots, a rise in the count of healthcare facilities, supportive government regulations, augmented healthcare expenditure, and the swift expansion of the elderly population.

The robotic surgery devices market size is expected to see rapid growth in the next few years. It will grow to $13.37 billion in 2028 at a compound annual growth rate (CAGR) of 14.4%. The anticipated growth in the forecast period is linked to the upsurge in product launches, the prevalence of minimally invasive surgeries, a higher incidence of chronic diseases, and an escalation in healthcare spending. Key drivers for this growth encompass emerging trends such as the incorporation of in-vivo robots in surgery services, ongoing advancements in technology, a surge in merger and acquisition activities, the integration of nanobots in surgery services, and the application of artificial intelligence in robotic surgery services.

The growth of the robotic surgery devices market is propelled by an increasing demand for minimally invasive technology. Minimally Invasive (MI) surgery devices, incorporating imaging and catheter technologies for easy insertion into various body parts, are contributing to the surge in demand. Robotic surgery procedures, often associated with minimally invasive surgeries, find application in heart, laparoscopy, orthopedic, gynecological, and urological surgeries. The introduction of robotic surgeries aims to diminish patient hospital length of stay (LOS), pain, complications, return to work time, and reoperations. According to a report from Intuitive Surgical, there is a year-on-year growth of 24% for instruments and accessories, 16% for robotic systems, and an overall market growth rate of 13%-16%. The company estimates that over 1.2 million surgical procedures have been conducted using their robotic systems. As consumer preferences shift, hospitals are increasingly adopting robotic surgery devices to enhance the value and cost-effectiveness of surgical procedures.

The anticipated growth of the robotic surgery devices market is further driven by the rising incidence of chronic diseases. Chronic diseases, characterized by their prolonged and persistent nature, are witnessing an increasing application of robotic surgery devices. These devices, with their ability to offer minimally invasive procedures, reduce complications, and improve surgical precision, are proving to be valuable tools in managing and treating chronic conditions across various medical specialties. For example, in September 2022, the World Health Organization reported 41 million deaths globally, with 74% attributed to non-communicable diseases (NCDs) or chronic diseases each year. Cardiovascular diseases accounted for 17.9 million deaths, cancer for 9.3 million deaths, chronic respiratory diseases for 4.1 million deaths, and diabetes for 2.0 million deaths. Consequently, the increasing incidence of chronic diseases is a significant factor propelling the growth of the robotic surgery devices market.


The progress in surgical products and technologies within the healthcare industry is generating increased opportunities in the robotic surgery devices market. Substantial investments in research and development (R&D) are empowering investors to deliver customer value through the production of cutting-edge medical-surgical products, including robotic surgery devices utilizing the latest technologies. The integration of robotic systems equipped with optical imaging, surgical tools, instruments, and accessories is simplifying surgical procedures. Various surgical advances are contributing significant value to the healthcare industry, such as 3-D high-definition endoscope devices for brain surgery, smart surgical glasses with video cameras and head-mounted monitors for live surgery observation, surgical robots with artificial intelligence functioning as doctors, humanoid robots for critical eye and brain surgeries, and remote robotics enabling surgery assistance from remote locations. Thus, robotic surgery devices play a pivotal role in the healthcare industry, driven by technological advancements and innovations.

Leading companies in the robotic surgery devices market are actively innovating new products to enhance their market profitability. An example is the introduction of R-One+, a medical robot system designed for heart surgery. In May 2023, Robocath, a France-based medical technology company, launched R-One+, aiming to improve treatment precision, safety, reduce radiation exposure, and enhance overall patient experience. The robotic platform, operated through a tablet and joystick, empowers interventional cardiologists to perform coronary angioplasties. This development represents a notable advancement in interventional cardiology, providing doctors with a tool to enhance patient outcomes and minimize risks during treatments.

In November 2022, SS Innovations International Inc., a US-based medical technology company, acquired Avra Medical Robotics for an undisclosed amount. This strategic acquisition expands SS Innovations' capability to offer a broader range of surgical robotic systems to a global audience. Avra Medical Robotics, known for its distinctive robotic platform in aesthetics, enhances SS Innovations' presence in that market segment. Avra Medical Robotics, a US-based medical technology company specializing in the manufacture of robotic surgery devices, aligns with SS Innovations' commitment to innovation and growth in the healthcare industry.


Major companies operating in the robotic surgery devices market report are Tenet Healthcare Corporation, HCA Healthcare, Inc., Asklepios Kliniken Verwaltungsgesellschaft Mbh, Apollo Hospitals Enterprise Ltd., Bumrungrad International Hospital, Fortis Healthcare, Bangkok Hospital, Spire Healthcare Group PLC, Saudi German Hospitals Group, Raffles Medical Group, SS Innovations Private Limited, Private Limited, CMR Surgical India Pvt. Ltd., Medicaroid Corp, Asahi Surgical Robotics Co Ltd., HOZ Medical, Medtronic PLC, Taimi Robotics Technology, Wenshi Robot, Borns Medical Robotics, Kewei Robot, Horizon Robotics, Avateramedical GmbH, Zimmer Biomet Holdings Inc., Medtech SA, KB Medical SA, Senhance, Archer Daniels Midland Company, Barentz Group Companies, CHR Hansen, Asensus Surgical, Intuitive, Medrobotics Corporation, Medical Inc., Smith & Nephew, Restoration Robotics, Hansen Medical, RTI Connext DDS, Robotic Surgerya, Stryker Corporation, Mazor Robotics, Renishaw PLC, Stereotaxis Inc., Capsa Healthcare, ReWalk Robotics, Hocoma, Accuray Incorporated, Corindus, InTouch Health Inc.

North America was the largest region in the robotic surgery devices market in 2023. Western Europe was the second largest market in global robotic surgery devices market. The regions covered in the robotic surgery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the robotic surgery devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain.

The primary offerings within the robotic surgery devices market include robotic systems, instruments and accessories, as well as services. The services, also known as robot-assisted surgery services, are delivered by the robotic systems. These devices find application in various surgical categories such as urological surgery, gynecological surgery, orthopedic surgery, neurosurgery, and others. These advanced tools are utilized in both hospital settings and ambulatory surgery centers.

The robotic surgery devices market research report is one of a series of new reports that provides robotic surgery devices market statistics, including robotic surgery devices industry global market size, regional shares, competitors with a robotic surgery devices market share, detailed robotic surgery devices market segments, market trends and opportunities, and any further data you may need to thrive in the robotic surgery devices industry. This robotic surgery devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Robotic surgery equipment market consist of sales of robotic systems, instruments and accessories that are used for robotic surgeries. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.